Founded in 1983, Breckenridge markets and distributes branded, high-quality, cost-effective generic and value-added medicines in the United States, under an own-label distribution model.
We act as a pharmaceutical partner, offering our developing and manufacturing partners a unique opportunity to reach the US society. Since 2007, Breckenridge has expanded to authorize generic (AGs), ANDAs, and Paragraph IV. Breckenridge has an experienced team that reaches all trade classes.
We market approximately 70 products in a variety of dosage forms including tablets, capsules, soft gel capsules, liquids, suspensions, ophthalmics, nasal sprays, and powders.
We have offices in New Jersey (New York) and Berlin (Connecticut).
Also, we have our 3PL located in La Vergne, Tennessee.